Healthcare
Live Price
Offline$0.0008
+0.00% today
1Y Change
+700.00%
Window
Jun 23, 2025 → Jun 17, 2026
Coverage: 251 bars · Jun 23, 2025 → Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Quick-Med Technologies, Inc. (QMDT) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 700.0% across the available one-year price window (Jun 23, 2025 → Jun 17, 2026). Baseline metrics include revenue growth of -6.9%, EPS growth of +57.7%, a dividend yield of 0.0%. What stands out right now is revenue -6.9%, EPS +57.7%, free cash flow +99.9% with operating margin -40.5% and ROIC -974.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines QMDT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QMDT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
QMDT Max Drawdown
-25.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for QMDT and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$1.0M
+1.1% YoY
FY Net Income
-$2.0M
+43.0% YoY
Free Cash Flow
-$846.9K
+39.5% YoY
Revenue Growth
-6.9%
EPS Growth
+57.7%
Gross Margin
69.8%
Net Margin
-76.8%
Income statement
USD
| Metric | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|
| Revenue | 928K | 997K | 1M | 994K | 1M |
| Gross Profit | 648K | 672K | 692K | 709K | 745K |
| Operating Income | -376K | -1M | -2M | -2M | -2M |
| EBITDA | -230K | -1M | -2M | -2M | -2M |
| Net Income | -713K | -2M | -2M | -4M | -2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|
| Cash & Equivalents | 50K | 81K | 949K | 628K | 41K |
| Total Assets | 723K | 612K | 2M | 1M | 493K |
| Total Liabilities | 10M | 9M | 8M | 8M | 5M |
| Shareholder Equity | -9M | -8M | -6M | -6M | -5M |
| Total Debt | 255K | 255K | 255K | 7M | 4M |
| Net Debt | 205K | 174K | -694K | 6M | 4M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
836K
+39.3% YoY
Capital Expenditures
11K
+49.4% YoY
Free Cash Flow
847K
+39.5% YoY
Key ratios
Gross Margin
69.8%
Operating Margin
-40.5%
Net Margin
-76.8%
ROE
8.3%
Debt / Equity
-0.03x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.